Ample evidence demonstrated that Adipolin/C1qdc2/CTRP12 and SFRP5 could regulate and improve glucose metabolism, inflammation level, insulin resistance (IR), and dyslipidemia. The gene discussed is SFRP5; the disease is Insulin resistance.